Optimal control analysis of HIV-TB co-infection model

DOI10.1007/978-3-030-46306-9_17zbMATH Open1480.92188OpenAlexW3038773240MaRDI QIDQ5016705FDOQ5016705

Rajiv Aggarwal, Tanvi Aggarwal

Publication date: 14 December 2021

Published in: Trends in Biomathematics: Modeling Cells, Flows, Epidemics, and the Environment (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1007/978-3-030-46306-9_17

Recommendations

• A TB-HIV/AIDS coinfection model and optimal control treatment
• An optimal treatment control of TB-HIV coinfection
• Estimating the impact of antiretroviral therapy on HIV-TB co-infection: optimal strategy prediction
• Assessing the effects of Holling type-II treatment rate on HIV-TB co-infection
• scientific article; zbMATH DE number 7615974

Mathematics Subject Classification ID

Epidemiology (92D30) Optimality conditions for problems involving partial differential equations (49K20)

Cites Work

• Modeling HIV/AIDS and tuberculosis coinfection
• Title not available (Why is that?)
• Impact of optimal control on the treatment of HIV/AIDS and screening of unaware infectives

Cited In (8)

• A co-infection model on TB - COVID-19 with optimal control and sensitivity analysis
• Optimal control of intervention strategies in malaria–tuberculosis co-infection with relapse
• A dynamical analysis and numerical simulation of COVID-19 and HIV/AIDS co-infection with intervention strategies
• Optimal control of TB transmission based on an age structured HIV-TB co-infection model
• A co‐infection model for oncogenic human papillomavirus and tuberculosis with optimal control and Cost‐Effectiveness Analysis
• Title not available (Why is that?)
• Dynamics of tuberculosis in HIV–HCV co-infected cases
• Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics

This page was built for publication: Optimal control analysis of HIV-TB co-infection model

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5016705)